We were interested to read about the long-term cumulative effect of ataluren treatment on FVC in DMD patients

A recent study by Michael et al. (2021) explores the long-term effects of ataluren on patients’ upper motor and respiratory function. Long-term cumulative treatment outcomes over a median period of 6.3 years on ataluren treatment indicated a delay in the loss of ambulation, a slower decline in forced vital capacity (FVC) and upper limb motor function even after loss of ambulation.

The Vitalograph Alpha was used to measure forced vital capacity in this study.

Read the full report: https://doi.org/10.1186/s12891-021-04700-z  

Learn how our custom solutions and personalized approach meet a wide range of respiratory clinical study needs.

Related Articles

We are excited to launch the next generation Alpha Spirometer, designed for testing on the go, remotely or in a clinic. The Alpha is our ultimate desktop spirometry solution. Comes with 5-year warranty with unlimited technical support.
We were at the very first Medica trade fair in Düsseldorf, showcasing our innovative spirometry technology. Both Medica and Vitalograph have come a long way since 1968.